LEXARIA BIOSCIENCE CORP. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
LEXARIA BIOSCIENCE CORP. (LEXX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $4.34 million as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-13
- 2026-05-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4.34M.
- 2026-02-28: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.21M.
- 2025-11-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4.52M.
- 2025-08-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.60M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-05-31 | $4.34M 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $6.21M 10-Q · filed 2026-07-13 | |
| 2025-11-30 | $4.52M 10-Q · filed 2026-07-13 | |
| 2025-08-31 | $2.60M 10-Q · filed 2026-07-13 | |
| 2025-05-31 | $5.17M 10-Q · filed 2026-07-13 | |
| 2025-02-28 | $6.76M 10-Q · filed 2026-07-13 | |
| 2024-11-30 | $9.39M 10-Q · filed 2026-07-13 | |
| 2024-08-31 | $7.66M 10-Q · filed 2026-07-13 | |
| 2024-05-31 | $9.75M 10-Q · filed 2025-07-14 | |
| 2024-02-29 | $6.15M 10-Q · filed 2025-07-14 | |
| 2023-11-30 | $3.37M 10-Q · filed 2025-07-14 | |
| 2023-08-31 | $2.68M 10-K · filed 2025-11-28 | |
| 2023-05-31 | $4.04M 10-Q · filed 2024-07-12 | |
| 2023-02-28 | $4.63M 10-Q · filed 2024-07-12 | |
| 2022-11-30 | $5.93M 10-Q · filed 2024-07-12 | |
| 2022-08-31 | $7.63M 10-K · filed 2024-11-26 | |
| 2022-05-31 | $8.91M 10-Q · filed 2023-07-14 | |
| 2022-02-28 | $11.22M 10-Q · filed 2023-07-14 | |
| 2021-11-30 | $11.47M 10-Q · filed 2023-07-14 | |
| 2021-09-30 | $11.47M 10-Q · filed 2022-07-14 | |
| 2021-08-31 | $13.06M 10-K · filed 2023-11-20 | |
| 2021-05-31 | $10.27M 10-Q · filed 2022-07-14 | $10.34M 10-Q · filed 2021-07-15 |
| 2021-02-28 | $11.70M 10-Q · filed 2022-07-14 | $11.70M 10-Q · filed 2021-04-14 |
| 2020-11-30 | $1.82M 10-Q · filed 2022-07-14 | |
| 2020-08-31 | $2.48M 10-K · filed 2022-11-28 | |
| 2020-05-31 | $3.20M 10-Q · filed 2021-04-14 | $3.20M 10-Q · filed 2020-06-29 |
| 2020-02-29 | $1.92M 10-Q · filed 2021-04-14 | |
| 2019-11-30 | $2.62M 10-Q · filed 2021-04-14 | $2.53M 10-Q · filed 2020-01-09 |
| 2019-08-31 | $2.49M 10-Q · filed 2021-04-14 | |
| 2019-05-31 | $3.32M 10-Q · filed 2020-06-29 | $3.18M 10-Q · filed 2019-07-08 |
| 2019-02-28 | $3.77M 10-Q · filed 2020-06-29 | $2.78M 10-Q · filed 2019-04-15 |
| 2018-11-30 | $3.41M 10-Q · filed 2020-06-29 | |
| 2018-08-31 | $2.39M 10-K · filed 2020-10-15 | |
| 2018-05-31 | $2.64M 10-Q · filed 2018-07-13 | |
| 2018-02-28 | $2.77M 10-Q · filed 2018-04-12 | |
| 2017-11-30 | $2.40M 10-Q · filed 2018-01-12 | |
| 2017-08-31 | $2.77M 10-K · filed 2019-11-14 | |
| 2017-05-31 | $3.06M 10-Q · filed 2017-07-14 | |
| 2017-02-28 | $490.57K 10-Q · filed 2017-04-14 | |
| 2016-11-30 | $623.34K 10-Q · filed 2017-01-13 | |
| 2016-08-31 | $87.76K 10-K · filed 2018-11-14 | |
| 2016-05-31 | -$45.28K 10-Q · filed 2016-07-13 | |
| 2016-02-29 | $105.15K 10-Q · filed 2016-04-13 | |
| 2015-11-30 | $318.73K 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $656.60K 10-K · filed 2018-11-14 | |
| 2015-05-31 | $1.14M 10-Q · filed 2015-07-14 | |
| 2015-02-28 | $1.17M 10-Q · filed 2015-04-14 | |
| 2014-11-30 | $1.46M 10-Q · filed 2015-01-14 | |
| 2014-08-31 | $1.72M 10-K · filed 2016-11-29 | |
| 2013-10-31 | $2.10M 10-K · filed 2015-11-27 | $2.10M 10-Q · filed 2015-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |